ARMC5
protein-codingarmadillo repeat containing 5, the group of Armadillo repeat containing
Gene summary
This gene encodes a member of the ARM (armadillo/beta-catenin-like repeat) superfamily. The ARM repeat is a tandemly repeated sequence motif with approximately 40 amino acid long. This repeat is implicated in mediating protein-protein interactions. The encoded protein contains seven ARM repeats. Mutations in this gene are associated with primary bilateral macronodular adrenal hyperplasia, which is also known as ACTH-independent macronodular adrenal hyperplasia 2. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Sep 2014]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~9.1 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AD
Disease ID:MONDO:0009049
Submitter: Orphanet
Inheritance Pattern: AD
Disease ID:MONDO:0014416
Submitter: Genomics England PanelApp
Inheritance Pattern: AD
Disease ID:MONDO:0014416
Submitter: Ambry Genetics
Inheritance Pattern: AD
Disease ID:MONDO:0014416
Submitter: Labcorp Genetics (formerly Invitae)
Clinical Genomic Database (CGD)
Manifestation: Endocrine; Oncologic
Intervention: Endocrine; Oncologic
Rationale: Surveillance for neoplasms, can allow early detection and treatment, which can involve surgical excision of the neoplasm or medical management (eg, targeting aberrant receptor expression) to control cortisol production
Comments: Germline variants in this tumor suppressor gene may result in the clinical phenotype in the presence of a second, somatic variant
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to ARMC5 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_001105247.2. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 76 | 8 | 84 | |||
| missense | 2 | 7 | 171 | 29 | 2 | 211 |
| nonsense | 5 | 6 | 1 | 12 | ||
| start loss | 0 | |||||
| frameshift | 9 | 11 | 1 | 21 | ||
| splice donor/acceptor (+/-2bp) | 1 | 3 | 4 | |||
| Total | 16 | 25 | 176 | 105 | 10 | 332 |
Highest pathogenic variant AF is 0.000019708317
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_001098717.1 | 6 | MANE Select | |
| Ensembl | ENSP00000268314.4 | 6 | MANE Select | |
| RefSeq | NP_001275696.1 | 8 | Standard | |
| RefSeq | NP_001288749.1 | 7 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Cushing,s syndrome - Homo sapiens (human)
Cellular Component
- nucleoplasm
- cytoplasm
- cytosol
- focal adhesion
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000268314
- Coding exons
- 6
- Length
- 9087
- Individuals with no LoFs
- 124838
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 16
- Defined
- 124854
- p
- 0.0000641
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 1.71 | 476 | 593 | 0.803 | 0.0000393 | 5660 |
| Missense (PolyPhen) | 135 | 243.76 | 0.55383 | 2355 | ||
| Synonymous | -2.21 | 319 | 273 | 1.17 | 0.0000169 | 2291 |
| Loss of Function | 3.54 | 7 | 26.8 | 0.262 | 0.00000149 | 268 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00020 | 0.00019 | rare |
| Latino/Admixed American | 0.000058 | 0.000058 | rare |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0.000056 | 0.000056 | rare |
| Finnish | 0.000049 | 0.000046 | rare |
| European (Non-Finnish) | 0.000063 | 0.000062 | rare |
| South Asian | 0.000033 | 0.000033 | rare |
| Other | 0.00017 | 0.00016 | rare |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Involved in fetal development, T-cell function and adrenal gland growth homeostasis (By similarity). Negatively regulates adrenal cells survival. Plays a role in steroidogenesis, modulates steroidogenic enzymes expression and cortisol production (PubMed:24283224, PubMed:28676429). {ECO:0000250|UniProtKB:Q5EBP3, ECO:0000269|PubMed:24283224, ECO:0000269|PubMed:28676429}.;
- Disease
- DISEASE: ACTH-independent macronodular adrenal hyperplasia 2 (AIMAH2) [MIM:615954]: A form of macronodular adrenal hyperplasia characterized by multiple, bilateral, non-pigmented, benign, adrenocortical nodules. It results in excessive production of cortisol leading to ACTH-independent Cushing syndrome. Clinical manifestations of Cushing syndrome include facial and truncal obesity, abdominal striae, muscular weakness, osteoporosis, arterial hypertension, diabetes. {ECO:0000269|PubMed:24283224, ECO:0000269|PubMed:24601692, ECO:0000269|PubMed:24708098, ECO:0000269|PubMed:24905064, ECO:0000269|PubMed:25822102, ECO:0000269|PubMed:25853793, ECO:0000269|PubMed:26604299, ECO:0000269|PubMed:27094308, ECO:0000269|PubMed:28458897, ECO:0000269|PubMed:28676429}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Intolerance Scores
- LoFtool
- 0.454
- RVIS EVS
- 0.25
- RVIS percentile EVS
- 69.69
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- S
- Essential (gene trap)
- N
- Indispensability pred.
- N
- Indispensability score
- 0.443
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |